Invention Grant
- Patent Title: Binding molecules specific for FcγRIIA and uses thereof
-
Application No.: US16097573Application Date: 2017-04-28
-
Publication No.: US11306145B2Publication Date: 2022-04-19
- Inventor: Katherine Ann Vousden , Bo Chen , Gary Patrick Sims
- Applicant: VIELA BIO, INC.
- Applicant Address: US MD Gaithersburg
- Assignee: VIELA BIO, INC.
- Current Assignee: VIELA BIO, INC.
- Current Assignee Address: US MD Gaithersburg
- Agency: Cooley, LLP
- International Application: PCT/EP2017/060188 WO 20170428
- International Announcement: WO2017/186908 WO 20171102
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/28 ; A61P7/00
Abstract:
The disclosure provides FcγRIIA-binding molecules, for example, humanized monoclonal antibodies capable of inhibiting FcγRIIA activity, and methods of using the FcγRIIA binding molecules, for example, in treating or preventing inflammatory, immune-mediated, or autoimmune diseases or disorders.
Public/Granted literature
- US20200002415A1 BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF Public/Granted day:2020-01-02
Information query
